Pfizer planning yet another plant expansion

In yet another expansion of its manufacturing operations, Pfizer ($PFE) plans to lay out nearly $150 million to build a sterile manufacturing facility and warehouse at its site near Kalamazoo, MI. It is the third manufacturing project the drug giant has unveiled in the last couple of months.

The New York-based drugmaker intends to invest about $105.6 million on a sterile manufacturing operation and another $40.8 million on a warehouse, Michigan Live reports. The projects, for which Pfizer is seeking tax breaks, are expected to add only about 15 jobs but are part of about $800 million in investments the company has told the city could come over the next decade. It indicated it has invested about that much at the site in the last 10 years.

Pfizer site leader Robert Betzig told WKZO radio that the new technology investments will help the Pfizer site stay competitive with plants in low-cost countries like India and China.

Free Webinar

What could you do with real-time supply chain information at your fingertips?

Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!

The 2,000-acre site in Kalamazoo County produces sterile injectables, nonsterile medications, biologicals, and other products, as well as 150 active pharmaceutical ingredients, steroids, antibiotics, and other Pfizer drugs, the company’s website indicates. It has about 2,100 employees at the site.

Pfizer is also seeking approval by authorities in Dublin, Ireland, to invest between €300 million and €400 million ($440.5 million) to build a 5-story, 34,500-square-meter (371,354-square-foot) biologics manufacturing unit at its Grange Castle manufacturing site. That  project is slated to result in 350 jobs and provide additional capacity for Pfizer arthritis drug Enbrel.

In June, Pfizer said it would spend $200 million to build a 175,000-square-foot facility at its campus in Andover, MA, also to produce complex biologics and vaccines.

- read the Michigan Live story
- get more from WKZO radio

Related Articles:
Pfizer expansion in Ireland would lead to 350 jobs
Pfizer planning Ireland biologics plant expansion
Pfizer adding $200M biologics facility to Andover, MA, campus


Suggested Articles

With a slate of vaccine authorizations on the horizon, vaccine execs from a trio of leading shot makers are looking at distribution hurdles ahead.

News of an FDA plant inspection for a Macrogenics drug boosted investor confidence in BMS' ability to meet its year-end deadline for liso-cel.

Pfizer is pushing back on a Thursday report claiming it suddenly revised its COVID-19 vaccine targets for 2020, saying it announced that last month.